// App-Quantinova.ai

AB0142 (2022) : EVIDENCE OF TYPE I INTERFERON ACTIVATION DURING VASCULAR MANIFESTATIONS OF SYSTEMIC SCLEROSIS

Researchers

Presenter

  • S. Di Donato

Principal Investigators

  • M. Hughes

  • G. Abignano

  • G. Lettieri

  • R. Ross

  • E. De Lorenzis

  • P. OConnor

  • O. Kubassova

  • F. Del Galdo

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

  • Università Campus Bio-Medico di Roma, Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, Rome, Italy

  • Centre for Musculoskeletal Research, The University of Manchester, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre,, Manchester, United Kingdom

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom

  • Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Division of Rheumatology, Rome, Italy

  • Image Analysis Group, Chief Executive Officer, London, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

  • Scleroderma

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved